RGC

Regencell Bioscience Holdings Ltd

NASDAQ: RGC · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC

$5.94

+5.13% today

Updated 2026-07-30

Market cap

$2.88B

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.01

Dividend yield

—

52W range

$5 – $69

Volume

0.3M

Market cap

$2.88B

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.01

Dividend yield

—

52W range

$5 – $69

Volume

0.3M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

5.3

Quality

C+

3.0

Profitability

5.0

Valuation

C+

2/9

Piotroski F-Score

Weak

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

—

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

Stock snapshot

Strengths

+ Debt/equity 0.32x — low leverage

Risks

- Piotroski 2/9 — weak financial health

- Thin margins at 0.00%

- Negative free cash flow $-2.59M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	—	—
Net income	$-7.42M	$-5.87M	$-4.30M	$-3.58M	$-5.32M
EPS	—	—	—	—	$-0.01
Free cash flow	$-6.05M	$-4.99M	$-4.01M	$-3.27M	$-2.59M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
RGC	$2.88B	19	4.3	3.0	5.0	5.3	—	Avoid
LLY	$1.02T	76	10.0	10.0	4.3	6.0	—	Strong Buy
JNJ	$615.36B	57	4.7	8.5	4.3	6.0	—	Buy
ABBV	$447.53B	63	4.0	8.0	4.7	5.0	-78.83%	Buy
UNH	$391.69B	62	7.3	5.5	4.0	6.0	-30.51%	Buy
MRK	$307.25B	50	3.3	8.0	2.7	5.0	-62.28%	Hold

Smart narrative

Regencell Bioscience Holdings Ltd trades at $5.94. Our Smart Value Score of 19/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score.

Frequently asked questions

What is Regencell Bioscience Holdings Ltd's stock price?

Regencell Bioscience Holdings Ltd (RGC) trades at $5.94.

Is Regencell Bioscience Holdings Ltd overvalued?

Regencell Bioscience Holdings Ltd carries a Smart Value Score of 19/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

Company info

SectorHEALTHCARE

IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC

CountryUSA

ExchangeNASDAQ

CurrencyUSD

www.regencellbioscience.com

Quick metrics

P/S ratio—

ROE-806.06%

Beta1.83

50D MA$14.02

200D MA$21.30

Shares out0.49B

Float0.06B

Short ratio—

Avg volume0.3M

Performance

1 week-15.83%

1 month-26.86%

3 months-15.51%

YTD-4.81%

1 year—

3 years—

5 years—

Compare

RGC vs LLY →RGC vs JNJ →RGC vs ABBV →Stock screener →